1955 Capital

Addie Harris is an Executive in Residence at 1955 Capital, focused on incubating new ventures and helping portfolio companies improve operations. She has over twenty years of experience as a founder and executive in medtech, medical devices, and robotics, including as founder and CEO of Cardan Robotics (acquired with sister company Mobius Imaging by Stryker in 2019) and as Global R&D Leader for Robotics at Johnson & Johnson, where she led the VELYS Robotic Surgical Solution launch. She also served as CEO of digital technology incubator Haventure SAS and holds engineering degrees from Tufts University and a computer science degree from Lincoln University in New Zealand.

Benjamin Tseng is a consultant with over a decade of experience in venture capital, product leadership, and AI research across deeptech sectors including cleantech, semiconductors, hardware, and healthcare. He has held product and operational roles at venture-backed companies including Yik Yak, Clint Health, Maximus, and Stir, and advised acquired companies Whistle and Dextro. His background includes venture investing at 1955 Capital and DCM, published research on AI/NLP methods for electronic medical records in collaboration with Stanford, and prior strategy consulting at Bain & Company.

Euan Thomson focuses on frontier health technologies at 1955 Capital, with an emphasis on data-driven healthcare, clinical decision-making, and system efficiency. He has over 30 years of experience across medical devices, digital health, and healthcare systems, including prior roles as a Partner at Khosla Ventures, President and CEO of Accuray (which he led through its 2007 IPO), President and CEO of Carl Zeiss Meditec, Head of Digital Health at Samsung, Global Head of R&D at Johnson & Johnson, and CEO of AliveCor. He holds a BS, MS, and PhD in Medical Physics from the University of London.

Jessie Zhan has over 30 years of experience in cross-border investment, finance, and risk management, with expertise in structuring and executing complex international transactions. She founded Aproin, a family office focused on cross-border investments, and serves as Chief Investment Advisor to CybEye and a board director of Toolots. Over her career she has led or participated in more than 150 transactions including IPOs, financings, M&A, and corporate restructurings. She holds a Bachelor's degree from Northeast Normal University, a Master's in Finance from the Institute of Fiscal Science at China's Ministry of Finance, and a PhD in Finance from Renmin University of China, and completed postdoctoral research at Tsinghua University.

Vijit Sabnis works on frontier technologies spanning health, energy, and advanced manufacturing at 1955 Capital, with over 20 years of experience as an inventor, founder, and investor in deep technology. He was previously a Partner at Khosla Ventures and co-founded and led Solar Junction, which commercialized high-efficiency solar cell technology; he is currently founding CEO of Adaptyx Biosciences, a biowearable health-monitoring company, and was a Co-founder-in-Residence at Deep Valley Labs. He holds a BS in Electrical Engineering and Computer Sciences from UC Berkeley and MS and PhD degrees in Electrical Engineering from Stanford University.

Yumin Liu focuses on renewables and advanced manufacturing at 1955 Capital, with more than 20 years of operating experience in solar energy, power generation, and energy systems. He is currently President, North America at Recurrent Energy, and previously served as Group CEO of ReneSola and held senior leadership roles at Canadian Solar overseeing EMEA operations. Earlier he was President of GCL Solar Energy, where he led international expansion and project development.